Enter OTP
Hannover, Germany
Undergraduate Fees International Students
Post Graduate Fees International Students
MHH spans an expansive, integrated campus comprising 48 interconnected buildings and covering around 400,000 m²—larger than 50 football fields. Recent expansions focus on sustainability and healing architecture with green courtyards, pedestrian-friendly walkways, and natural materials to support patient care and academic work
The below information is required while
completing the university application :
Secondary school leaving certificate equivalent to the German Abitur (12+ years of education).
High academic scores in relevant subjects (especially biology, chemistry, mathematics).
Proof of German language proficiency (e.g. TestDaF, DSH) – most bachelor’s programs are taught in German.
University entrance qualification recognized in Germany (via uni-assist for international students).
Pre-medical or entrance exam may be required for some programs (e.g., medicine).
Good scores in TestAS (for international applicants – recommended, not mandatory).
Motivational letter and CV may strengthen your application.
Know more
MHH was ranked among the top clinical and health universities globally by Times Higher Education, reflecting its excellence in teaching, patient care, and scientific innovation.
During the pandemic, MHH became a leading center for COVID-19 treatment and vaccine trials in Germany. It participated in early clinical trials of therapies, including antiviral drugs and vaccine candidates.
Although awarded to virologist Harald zur Hausen for his discovery of HPV as a cause of cervical cancer, his early academic collaborations with MHH highlighted the university's role in virological and oncological research.
In 2022, researchers at MHH advanced 3D-bioprinting technology to create human tissue scaffolds and miniature organ models (organoids) for use in transplant research and drug testing. These bioprinted models are crucial for future organ regeneration.
In collaboration with technical universities and startups, MHH introduced AI-based diagnostic systems in 2020 to detect neurological diseases like Alzheimer’s and Parkinson’s through imaging and predictive modeling. These systems improve early detection and patient monitoring.
In the early 2000s, MHH pioneered the concept of personalized cancer vaccines, especially in treating leukemia and melanoma. In 2001, its research into dendritic cell-based immunotherapy gained international recognition, influencing cancer treatment protocols across Europe.
Embark on your educational journey with confidence! Our team of admission experts is here to guide you through the process. Book a free session now to receive personalized advice, assistance with applications, and insights into your dream school. Whether you're applying to college, graduate school, or specialized programs, we're here to help you succeed.
